{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:03:50Z","timestamp":1786118630221,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/01.ta.0000233909.88264.43","type":"journal-article","created":{"date-parts":[[2007,4,10]],"date-time":"2007-04-10T04:11:44Z","timestamp":1176178304000},"page":"E111-E115","source":"Crossref","is-referenced-by-count":2,"title":["Low-Molecular-Weight Heparin for Prevention of Thrombosis: Inverted Role"],"prefix":"10.1097","volume":"63","author":[{"given":"Zoe H.","family":"Dailiana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos N.","family":"Malizos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sokratis","family":"Varitimidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Basdekis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Rigopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-38-20210211","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1302\/0301-620X.82B4.0820475","article-title":"Risks and benefits of profhylaxis against venous thromboembolism in orthopaedic surgery.","volume":"82B","author":"Gillespie","year":"2000","journal-title":"J Bone Joint Surg Br"},{"key":"R2-38-20210211","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00003086-200105000-00016","article-title":"Treatment of avascular necrosis of the femoral head with vascularized fibular transplant.","volume":"386","author":"Soucacos","year":"2001","journal-title":"Clin Orthop"},{"key":"R3-38-20210211","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0140-6736(92)93223-A","article-title":"Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis.","volume":"340","author":"Nurmohamed","year":"1992","journal-title":"Lancet"},{"key":"R4-38-20210211","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00003086-200111000-00031","article-title":"Low molecular weight heparin prophylaxis in total knee arthroplasty: the answer.","volume":"392","author":"Colwell","year":"2001","journal-title":"Clin Orthop"},{"key":"R5-38-20210211","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/archsurg.1979.01370280026004","article-title":"White clot syndrome. Peripheral vascular complications of heparin therapy.","volume":"114","author":"Towne","year":"1979","journal-title":"Arch Surg"},{"key":"R6-38-20210211","first-page":"257","article-title":"Heparin-induced thrombocytopenia.","volume":"218","author":"Bottiger","year":"1985","journal-title":"Acta Med Scand"},{"key":"R7-38-20210211","first-page":"618","article-title":"Venous gangrene associated with heparin-induced thrombocytopenia.","volume":"97","author":"Battey","year":"1985","journal-title":"Surgery"},{"key":"R8-38-20210211","first-page":"173","article-title":"Heparin-induced thrombocytopenia.","volume":"16","author":"Kelton","year":"1986","journal-title":"Haemostasis"},{"key":"R9-38-20210211","first-page":"378","article-title":"Heparin-induced thrombocytopenia.","volume":"12","author":"Baldwin","year":"1989","journal-title":"J Intraven Nurs"},{"key":"R10-38-20210211","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00320647","article-title":"Heparin-induced thrombocytopenia.","volume":"58","author":"Chong","year":"1989","journal-title":"Blut"},{"key":"R11-38-20210211","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1358836X0100600208","article-title":"Heparin-induced thrombocytopenia: natural history, diagnosis, and management.","volume":"6","author":"Deitcher","year":"2001","journal-title":"Vasc Med"},{"key":"R12-38-20210211","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1055\/s-2007-996138","article-title":"Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis.","volume":"23","author":"Alving","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"R13-38-20210211","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"R14-38-20210211","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1054\/blre.2001.0189","article-title":"Heparin-induced thrombocytopenia: an overview.","volume":"16","author":"Kelton","year":"2002","journal-title":"Blood Rev"},{"key":"R15-38-20210211","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-2007-1000384","article-title":"Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic and the immunologic type are closely linked in their pathogenesis.","volume":"21","author":"Greinacher","year":"1995","journal-title":"Thromb Haemostas"},{"key":"R16-38-20210211","first-page":"115","article-title":"Low-molecular weight heparin in the therapy of heparin-induced thrombocytopenia.","volume":"82","author":"Reuter","year":"1987","journal-title":"Med Klin"},{"key":"R17-38-20210211","first-page":"68","article-title":"Diagnostic tests in heparin-induced thrombocytopenia.","volume":"8","author":"Amiral","year":"1997","journal-title":"Platelets"},{"issue":"Suppl 5","key":"R18-38-20210211","first-page":"3","article-title":"Pathophysiology and laboratory testing of heparin-induced thrombocytopenia.","volume":"35","author":"Chong","year":"1998","journal-title":"Semin Hematol"},{"key":"R19-38-20210211","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1302\/0301-620X.84B4.0840588","article-title":"Limb loss following the use of heparin. A lesson to be remembered.","volume":"84","author":"Lam","year":"2002","journal-title":"J Bone Joint Surg Br"},{"key":"R20-38-20210211","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00007611-199802000-00002","article-title":"Cardiology for the primary care provider: heparin-induced thrombocytopenia.","volume":"91","author":"Benton","year":"1998","journal-title":"South Med J"},{"key":"R21-38-20210211","first-page":"72","article-title":"Heparin-induced thrombocytopenia.","volume":"85","author":"Fabris","year":"2000","journal-title":"Haematologica"},{"key":"R22-38-20210211","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/intimm\/14.2.121","article-title":"Anti-platelet factor 4\/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells.","volume":"14","author":"Blank","year":"2002","journal-title":"Int Immunol"},{"key":"R23-38-20210211","first-page":"66","article-title":"Pathophysiology of heparin-induced thrombocytopenia (HIT).","volume":"8","author":"Mikhailidis","year":"1997","journal-title":"Platelets"},{"key":"R24-38-20210211","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2004-01-0058","article-title":"The homozygous FcgammaRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin\/platelet factor 4 complexes.","volume":"104","author":"Gruel","year":"2004","journal-title":"Blood"},{"key":"R25-38-20210211","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1537-2995.1994.34594249047.x","article-title":"Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test and platelet factor 4\/heparin enzyme linked immunosorbent assay.","volume":"34","author":"Greinacher","year":"1994","journal-title":"Transfusion"},{"key":"R26-38-20210211","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V88.2.410.bloodjournal882410","article-title":"Presence of autoantibodies to interleukin-8 or neutral activating peptide-2 in patients with heparin-associated thrombocytopenia.","volume":"88","author":"Amiral","year":"1996","journal-title":"Blood"},{"issue":"Suppl","key":"R27-38-20210211","first-page":"7","article-title":"Antigens involved in heparin-induced thrombocytopenia.","volume":"36","author":"Amiral","year":"1999","journal-title":"Semin Hematol"},{"key":"R28-38-20210211","first-page":"1","article-title":"Heparin-induced thrombocytopenia.","volume":"10","author":"Warkentin","year":"1991","journal-title":"Prog Hemost Thromb"},{"key":"R29-38-20210211","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0741-5214(03)00769-9","article-title":"Heparin-induced thrombocytopenia: twenty-nine years later.","volume":"38","author":"Shuster","year":"2003","journal-title":"J Vasc Surg"},{"key":"R30-38-20210211","first-page":"61","article-title":"Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.","volume":"93","author":"Jeske","year":"2004","journal-title":"Methods Mol Med"},{"key":"R31-38-20210211","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(02)08648-8","article-title":"Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.","volume":"359","author":"Turpie","year":"2002","journal-title":"Lancet"},{"key":"R32-38-20210211","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1055\/s-0038-1649949","article-title":"Absence of in vitro cross-reaction of pentasaccharide with plasma heparin dependent factor of twenty-five patients with heparin associated thrombocytopenia.","volume":"74","author":"Elalamy","year":"1995","journal-title":"Thromb Haemost"},{"key":"R33-38-20210211","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0037-1614411","article-title":"Prevention of deep vein thrombosis after hip replacement-comparison between two low-molecular heparins, tinzaparin and enoxaparin.","volume":"81","author":"Planes","year":"1999","journal-title":"Thromb Haemost"},{"key":"R34-38-20210211","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00001721-199610000-00001","article-title":"A fatal low-molecular-weight heparin associated thrombocytopenia after hip surgery: possible usefulness of PF4-heparin Elisa test.","volume":"7","author":"Elalamy","year":"1996","journal-title":"Blood Coagul and Fibrinolysis"},{"key":"R35-38-20210211","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1055\/s-2008-1039385","article-title":"Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin.","volume":"137","author":"Marx","year":"1999","journal-title":"Z Orthop Ihre Grenzgeb"},{"key":"R36-38-20210211","first-page":"49","article-title":"Heparin-associated thrombocytopenia caused by low-molecular-weight heparin.","volume":"98","author":"Koninger","year":"1995","journal-title":"Unfallchirurg"},{"key":"R37-38-20210211","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2106\/00004623-197759080-00010","article-title":"Arterial thromboembolism in patients receiving systemic heparin therapy.","volume":"59","author":"Baird","year":"1977","journal-title":"J Bone Joint Surg Am"}],"container-title":["Journal of Trauma: Injury, Infection &amp; Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.ta.0000233909.88264.43","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:34:11Z","timestamp":1786034051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005373-200711000-00038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ta.0000233909.88264.43","relation":{},"ISSN":["0022-5282"],"issn-type":[{"value":"0022-5282","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}